Related Experiment Video
Updated: Feb 22, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
Dementia with Lewy bodies: cerebrospinal fluid suppresses neuronal network activity
Stephan Theiss1, Walter Maetzler, Christian Deuschle
1aInstitute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University bResult Medical GmbH, Düsseldorf cDepartment of Neurodegeneration, Center for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen dDZNE, German Center for Neurodegenerative Diseases eDepartment of Epileptology, Center for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen fDepartment of Neurology, Kiel University, Keil, Germany.
Abstract:
One of the core clinical criteria of Dementia with Lewy bodies (DLB) are fluctuations of cognition. Underlying processes may be rather functional than neurodegenerative, reflected by, for example, factors present in cerebrospinal fluid (CSF). The aim of this study was to identify in-vitro neuronal network activity (ivNNA) changes of CSF from DLB patients compared with patients with Parkinson's disease (PD) and controls. Primary neuronal mouse cultures were grown on microelectrode arrays to record ivNNA when exposed to respective CSF samples. If exposed to CSF of DLB patients, ivNNA showed a reduced spike rate and burst rate compared with CSF of PD patients and controls. Our data are suggestive of the presence of functional factors in the CSF of DLB patients that differentiate network activity from PD patients and controls. Future studies should evaluate whether this pilot observation might be related to fluctuations of cognition in DLB.
Related Concept Videos
Neural Regulation
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
The Blood-brain Barrier
Dementia
The progression of dementia is generally gradual....

